Convalescent Plasma COVID-19: No Credit
Convalescent Plasma COVID-19 - LIVESTREAM
Few treatments beyond supportive measures are available for patients critically ill with COVID-19. However, infusions of convalescent donor plasma have demonstrated improvement in patient outcomes for illnesses like Ebola, and Mayo Clinic is currently leading a multi-center expanded access program to study treatment of COVID-19 with plasma.
This livestream event educates clinicians and scientists; allied health staff; and regulators and industry executives on treatment of hospitalized patients with severe or life-threatening COVID-19. Topics covered include the history and evolution of convalescent plasma therapies; implementation of the ongoing expanded access program for COVID-19 patients; current data; blood bank and donor recruitment strategies; and world perspectives on treatment of COVID-19 patients with plasma.
This four-hour livestream activity includes lectures and interactive activity, as well as moderated poster presentations and case sessions.
Call for Abstracts
Authors are invited to submit Abstracts for consideration as part of the Convalescent Plasma COVID-19 Livestreaming event.
Click here to learn about Abstract criteria and to submit an Abstract.
This activity is intended for health care providers treating patients with COVID-19. It is designed for Physicians, Scientist Researcher PhD., Physician Assistants, Nurse Practitioners, Nurses, Pharmacists, Residents, Fellows and Students.
Upon conclusion of this program, participants should be able to:
- Explain how to make use of convalescent plasma for treatment of COVID-19 patients.
- Discuss the current outcomes data for the use of convalescent plasma for treatment of COVID-19 patients.
- Review content from moderated poster sessions and case studies that may not currently be available in the published literature given the newness of this disease.
- Describe support options for clinicians for the use of plasma and resources for sending their patients to donate.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
To ensure you have timely access to the latest medical education in an interactive format, this course will be offered via livestreaming.
You will receive an email on how to connect approximately a week before the event.
C. Scott Collins, M.D.
Michael J. Joyner, M.D.
R. Scott Wright, M.D.
Mayo Clinic Faculty
Katelyn A. Bruno, Ph.D.
Rickey E. Carter, Ph.D.
DeLisa Fairweather, Ph.D.
Suraj Kapa, M.D.
Kathryn F. Larson, M.D.
Jonathon (Jack) Senefeld, Ph.D.
Camille van Buskirk, M.D.
Arturo Casadevall, M.D., Ph.D.
Hiba Saud AlHumaidan, M.D.
Sheikh Khalifa Medical City
Abu Dhabi, UAE
Peter Marks, M.D., Ph.D.
Federal Drug Administration
Silver Springs, Maryland
Liise-anne Pirofski, M.D.
Albert Einstein College of Medicine and Montefiore Medical Center
Bronx, New York
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
- 4.00 Attendance
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to email@example.com. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.